Update on Normal Tension Glaucoma

Jyotiranjan Mallick, Lily Devi, Pradeep K Malik, Jogamaya Mallick, Jyotiranjan Mallick, Lily Devi, Pradeep K Malik, Jogamaya Mallick

Abstract

Normal tension glaucoma (NTG) is labelled when typical glaucomatous disc changes, visual field defects and open anterior chamber angles are associated with intraocular pressure (IOP) constantly below 21 mmHg. Chronic low vascular perfusion, Raynaud's phenomenon, migraine, nocturnal systemic hypotension and over-treated systemic hypertension are the main causes of normal tension glaucoma. Goldmann applanation tonometry, gonioscopy, slit lamp biomicroscopy, optical coherence tomography and visual field analysis are the main tools of investigation for the diagnosis of NTG. Management follows the same principles of treatment for other chronic glaucomas: To reduce IOP by a substantial amount, sufficient to prevent disabling visual loss. Treatment is generally aimed to lower IOP by 30% from pre-existing levels to 12-14 mmHg. Betaxolol, brimonidine, prostaglandin analogues, trabeculectomy (in refractory cases), systemic calcium channel blockers (such as nifedipine) and 24-hour monitoring of blood pressure are considered in the management of NTG. The present review summarises risk factors, causes, pathogenesis, diagnosis and management of NTG.

Keywords: Normal Tension Glaucoma; Ocular Hypoperfusion; Vasospasm.

Figures

Figure 1
Figure 1
Optic disc in normal tension glaucoma.

References

    1. Werner EB. Ritch R, Shields MB, Krupin T. The Glaucomas. 2nd ed. St. Louis: Mosby-Year Book; 1996. Normal-tension glaucoma; pp. 769–797.
    1. Quigley HA. Glaucoma. Lancet. 2011;377:1367–1377.
    1. Resnikoff S, Pascolini D, Etya’ale D, Kocur I, Pararajasegaram R, Pokharel GP, et al. Global data on visual impairment in the year 2002. Bull World Health Organ. 2004;82:844–851.
    1. Quigley HA, Broman AT. The number of people with glaucoma worldwide in 2010 and 2020. Br J Ophthalmol. 2006;90:262–267.
    1. Berenson K, Kymes S, Walt JG, Siegartel LR. The relationship of mean deviation scores and resource utilization among patients with glaucoma: A retrospective United States and European chart review analysis. J Glaucoma. 2009;18:390–394.
    1. Iwase A, Suzuki Y, Araie M, Yamamoto T, Abe H, Shirato S, et al. The prevalence of primary open-angle glaucoma in Japanese: The Tajimi study. Ophthalmology. 2004;111:1641–1648.
    1. Kanski JJ, Bowling B, Nischal K, Pearson R. 7th ed. Edinburgh: Elsevier Saunders; 2011. Clinical Ophthalmology: A Systematic Approach; pp. 346–348.
    1. Flammer J, Mozaffarieh M. What is the present pathogenetic concept of glaucomatous optic neuropathy? Surv Ophthalmol. 2007;52(Suppl 2):S162–S173.
    1. The advanced glaucoma intervention study (AGIS): 7. The relationship between control of intraocular pressure and visual field deterioration. The AGIS Investigators. Am J Ophthalmol. 2000;130:429–440.
    1. Lichter PR, Musch DC, Gillespie BW, Guire KE, Janz NK, Wren PA, et al. Interim clinical outcomes in the collaborative initial glaucoma treatment study comparing initial treatment randomized to medications or surgery. Ophthalmology. 2001;108:1943–1953.
    1. The effectiveness of intraocular pressure reduction in the treatment of normal-tension glaucoma. Collaborative Normal-Tension Glaucoma Study Group. Am J Ophthalmol. 1998;126:498–505.
    1. Heijl A, Leske MC, Bengtsson B, Hyman L, Bengtsson B, Hussein M Early Manifest Glaucoma Trial Group. Reduction of intraocular pressure and glaucoma progression: Results from the early manifest glaucoma trial. Arch Ophthalmol. 2002;120:1268–1279.
    1. Gramer E, Leydhecker W. Glaucoma without ocular hypertension. A clinical study. Klin Monbl Augenheilkd. 1985;186:262–267.
    1. Shields MB. Normal-tension glaucoma: Is it different from primary open-angle glaucoma? Curr Opin Ophthalmol. 2008;19:85–88.
    1. Shetgar AC, Mulimani MB. The central corneal thickness in normal tension glaucoma, primary open angle glaucoma and ocular hypertension. J Clin Diagn Res. 2013;7:1063–1067.
    1. Comparison of glaucomatous progression between untreated patients with normal-tension glaucoma and patients with therapeutically reduced intraocular pressures. Collaborative Normal-Tension Glaucoma Study Group. Am J Ophthalmol. 1998;126:487–497.
    1. Flammer J, Orgül S, Costa VP, Orzalesi N, Krieglstein GK, Serra LM, et al. The impact of ocular blood flow in glaucoma. Prog Retin Eye Res. 2002;21:359–393.
    1. Demailly P, Cambien F, Plouin PF, Baron P, Chevallier B. Do patients with low tension glaucoma have particular cardiovascular characteristics? Ophthalmologica. 1984;188:65–75.
    1. Tielsch JM, Katz J, Sommer A, Quigley HA, Javitt JC. Hypertension, perfusion pressure, and primary open-angle glaucoma. A population-based assessment. Arch Ophthalmol. 1995;113:216–221.
    1. Anderson DR. Glaucoma, capillaries and pericytes 1. Blood flow regulation. Ophthalmologica. 1996;210:257–262.
    1. Mozaffarieh M, Flammer J. Ch 5. London: Current Medical Group; 2008. Pocket reference to ocular blood flow and glaucomatous optic atrophy.
    1. Mozaffarieh M, Flammer J. Ch 7. London: Current Medical Group; 2008. Pocket reference to ocular blood flow and glaucomatous optic atrophy.
    1. Drance SM. Some factors in the production of low tension glaucoma. Br J Ophthalmol. 1972;56:229–242.
    1. Henry E, Newby DE, Webb DJ, O’Brien C. Peripheral endothelial dysfunction in normal pressure glaucoma. Invest Ophthalmol Vis Sci. 1999;40:1710–1714.
    1. Kim SH, Kim JY, Kim DM, Ko HS, Kim SY, Yoo T, et al. Investigations on the association between normal tension glaucoma and single nucleotide polymorphisms of the endothelin-1 and endothelin receptor genes. Mol Vis. 2006;12:1016–1021.
    1. Phelps CD, Corbett JJ. Migraine and low-tension glaucoma. A case-control study. Invest Ophthalmol Vis Sci. 1985;26:1105–1108.
    1. Schulzer M, Drance SM, Carter CJ, Brooks DE, Douglas GR, Lau W. Biostatistical evidence for two distinct chronic open angle glaucoma populations. Br J Ophthalmol. 1990;74:196–200.
    1. Leung DY, Tham CC, Li FC, Kwong YY, Chi SC, Lam DS. Silent cerebral infarct and visual field progression in newly diagnosed normal-tension glaucoma: A cohort study. Ophthalmology. 2009;116:1250–1256.
    1. Mojon DS, Hess CW, Goldblum D, Fleischhauer J, Koerner F, Bassetti C, et al. High prevalence of glaucoma in patients with sleep apnea syndrome. Ophthalmology. 1999;106:1009–1012.
    1. Bilgin G. Normal-tension glaucoma and obstructive sleep apnea syndrome: A prospective study. BMC Ophthalmol. 2014;14:27.
    1. Nesher R, Kohen R, Shulman S, Siesky B, Nahum Y, Harris A. Diastolic double-product: A new entity to consider in normal-tension glaucoma patients. Isr Med Assoc J. 2012;14:240–243.
    1. Park HY, Park SH, Park CK. Central visual field progression in normal-tension glaucoma patients with autonomic dysfunction. Invest Ophthalmol Vis Sci. 2014;55:2557–2563.
    1. Abegão Pinto L, Vandewalle E, De Clerck E, Marques-Neves C, Stalmans I. Lack of spontaneous venous pulsation: Possible risk indicator in normal tension glaucoma? Acta Ophthalmol. 2013;91:514–520.
    1. Ritch R, Darbro B, Menon G, Khanna CL, Solivan-Timpe F, Roos BR, et al. TBK1 gene duplication and normal-tension glaucoma. JAMA Ophthalmol. 2014;132:544–548.
    1. Lee AJ, Rochtchina E, Wang JJ, Healey PR, Mitchell P. Does smoking affect intraocular pressure. Findings from the Blue Mountains Eye Study? J Glaucoma. 2003;12:209–212.
    1. Kim M, Jeoung JW, Park KH, Oh WH, Choi HJ, Kim DM. Metabolic syndrome as a risk factor in normal-tension glaucoma. Acta Ophthalmol. 2014;92:e637–e643.
    1. Anderson DR. Correlation of the peripapillary anatomy with the disc damage and field abnormalities in glaucoma. Doc Ophthalmol Proc Ser. 1983;35:1–10.
    1. Buus DR, Anderson DR. Peripapillary crescents and halos in normal-tension glaucoma and ocular hypertension. Ophthalmology. 1989;96:16–19.
    1. Heijl A, Samander C. Peripapillary atrophy and glaucomatous visual field defects. Doc Ophthalmol Proc Ser. 1985;42:403.
    1. Javitt JC, Spaeth GL, Katz LJ, Poryzees E, Addiego R. Acquired pits of the optic nerve. Increased prevalence in patients with low-tension glaucoma. Ophthalmology. 1990;97:1038–1043.
    1. Park HY, Lee KI, Lee K, Shin HY, Park CK. Torsion of the optic nerve head is a prominent feature of normal-tension glaucoma. Invest Ophthalmol Vis Sci. 2014;56:156–163.
    1. Hirooka K, Tenkumo K, Fujiwara A, Baba T, Sato S, Shiraga F. Evaluation of peripapillary choroidal thickness in patients with normal-tension glaucoma. BMC Ophthalmol. 2012;12:29.
    1. Gramer E, Althaus G, Leydhecker W. Site and depth of glaucomatous visual field defects in relation to the size of the neuroretinal edge zone of the optic disk in glaucoma without hypertension, simple glaucoma, pigmentary glaucoma. A clinical study with the octopus perimeter 201 and the optic nerve head analyzer. Klin Monbl Augenheilkd. 1986;189:190–198.
    1. Gliklich RE, Steinmann WC, Spaeth GL. Visual field change in low-tension glaucoma over a five-year follow-up. Ophthalmology. 1989;96:316–320.
    1. Gramer E, Althaus G. Quantification and progression of the visual field defect in glaucoma without hypertension, glaucoma simplex and pigmentary glaucoma. A clinical study with the delta program of the 201 octopus perimeter. Klin Monbl Augenheilkd. 1987;191:184–198.
    1. Allingham RR, Damji KF, Freedman SF, Moroi SE, Rhee DJ, Shields MB. 6th ed. Philadelphia, PA: Lippincott Williams and Wilkins; 2010. Shields’ Textbook of Glaucoma; p. 180.
    1. Kim TW, Kim M, Lee EJ, Jeoung JW, Park KH. Intraocular pressure-lowering efficacy of dorzolamide/timolol fixed combination in normal-tension glaucoma. J Glaucoma. 2014;23:329–332.
    1. Feke GT, Bex PJ, Taylor CP, Rhee DJ, Turalba AV, Chen TC, et al. Effect of brimonidine on retinal vascular autoregulation and short-term visual function in normal tension glaucoma. Am J Ophthalmol. 2014;158:105–112.e1.
    1. Schulzer M. Intraocular pressure reduction in normal-tension glaucoma patients. The Normal Tension Glaucoma Study Group. Ophthalmology. 1992;99:1468–1470.
    1. Bloomfield S. The results of surgery for low-tension glaucoma. Am J Ophthalmol. 1953;36:1067–1070.
    1. Sugar HS. Low tension glaucoma: A practical approach. Ann Ophthalmol. 1979;11:1155–1171.
    1. Abedin S, Simmons RJ, Grant WM. Progressive low-tension glaucoma: Treatment to stop glaucomatous cupping and field loss when these progress despite normal intraocular pressure. Ophthalmology. 1982;89:1–6.
    1. Lee JW, Gangwani RA, Chan JC, Lai JS. Prospective study on the efficacy of treating normal tension glaucoma with a single session of selective laser trabeculoplasty. J Glaucoma. 2015;24:77–80.
    1. Suominen S, Harju M, Kurvinen L, Vesti E. Deep sclerectomy in normal-tension glaucoma with and without mitomycin-c. Acta Ophthalmol. 2014;92:701–706.
    1. Chumbley LC, Brubaker RF. Low-tension glaucoma. Am J Ophthalmol. 1976;81:761–767.
    1. Sawada A, Kitazawa Y, Yamamoto T, Okabe I, Ichien K. Prevention of visual field defect progression with brovincamine in eyes with normal-tension glaucoma. Ophthalmology. 1996;103:283–288.
    1. Koseki N, Araie M, Tomidokoro A, Nagahara M, Hasegawa T, Tamaki Y, et al. A placebo-controlled 3-year study of a calcium blocker on visual field and ocular circulation in glaucoma with low-normal pressure. Ophthalmology. 2008;115:2049–2057.
    1. Netland PA, Chaturvedi N, Dreyer EB. Calcium channel blockers in the management of low-tension and open-angle glaucoma. Am J Ophthalmol. 1993;115:608–613.

Source: PubMed

Sponsors and Collaborators

Medical Conditions

Drug Interventions

3
Subscribe